FDA Okays Lilly’s Tauvid as First Drug to Image Tau Pathology

FDA approved Eli Lilly’s Tauvid (flortaucipir F18) for intravenous injection as the first drug used to help image a distinctive characteristic of Alzheimer’s disease in the brain called tau pathology.

• FDA granted approval to Eli Lilly’s Avid Radiopharmaceuticals

To view the source of this information click here

--With assistance from Catherine Larkin.

To contact the reporter on this story:
Linly Lin in San Francisco at llin153@bloomberg.net

To contact the editor responsible for this story:
Chakradhar Adusumilli at cadusumilli@bloomberg.net

© 2020 Bloomberg L.P. All rights reserved. Used with permission.